ETAL5-RELEVANT

Hematological neoplasms
Myelodysplastic Syndrome (MDS), Acute myeloid leukemia
other systemic therapies
Randomized comparison of conditioning with treosulfan or melphalan in AML and MDS patients scheduled for allogeneic stem cell transplantation (alloHCT) and subsequent GvHD prophylaxis with cyclophosphamide (RELEVANT)
Randomized comparison of conditioning with treosulfan or melphalan in AML and MDS patients scheduled for allogeneic stem cell transplantation (alloHCT) and subsequent GvHD prophylaxis with cyclophosphamide (RELEVANT)